Funds and ETFs Pharmaron Beijing Co., Ltd.
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.71 CNY | +3.88% | +9.92% | -25.09% |
04-30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
04-29 | Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy | MT |
ETFs positioned on Pharmaron Beijing Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 0 M€ | -12.22% | - | |
0.13% | 35 M€ | -5.85% | - | |
0.10% | 0 M€ | +5.65% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 4 M€ | -11.56% | ||
0.03% | 7 M€ | -.--% | - | |
0.01% | 0 M€ | +3.95% | - | |
0.01% | 0 M€ | +8.81% | - | |
0.01% | 0 M€ | +8.01% | - | |
0.01% | 0 M€ | +5.91% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +4.81% | - | |
0.00% | 0 M€ | +3.63% | - | |
0.00% | 0 M€ | +14.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.09% | 4.88B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 300759 Stock
- Funds and ETFs Pharmaron Beijing Co., Ltd.